Anna McNamara
CIK 1442785 · Senior Vice Pres/Clinical Op. · last filed 2013-02-21
Anna McNamara is a Senior Vice Pres/Clinical Op. who has filed 13 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing, for BEAT, was dated Feb 21, 2013. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $68.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$68.9K
1
13
-$2.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BEAT | Senior Vice Pres/Clinical Op. | 90,903 | $0.76 | $68.9K | -$2.00M | 13 | 2013-02-21 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-02-21 | BEAT | Grant (A) | +19,282 | $0 | EDGAR |
| 2012-02-23 | BEAT | Grant (A) | +28,693 | $0 | EDGAR |
| 2011-04-01 | BEAT | Grant (A) | +10,021 | $0 | EDGAR |
| 2011-03-08 | BEAT | Grant (A) | +10,021 | $0 | EDGAR |
| 2010-05-11 | BEAT | Grant (A) | +5,119 | $0 | EDGAR |
| 2009-10-27 | BEAT | Grant (A) | +20,000 | $0 | EDGAR |
| 2009-08-14 | BEAT | Grant (A) | — | $0 | EDGAR |
| 2009-03-06 | BEAT | Grant (A) | +7,788 | $0 | EDGAR |
| 2008-11-17 | BEAT | Sell (S) | −10,999 | -$248.0K | EDGAR |
| 2008-11-14 | BEAT | Sell (S) | −22,000 | -$486.8K | EDGAR |